Prefer a chat interface with context about you and your work?
An adaptive design for identifying the dose with the best efficacy/tolerability profile with application to a crossover dose‐finding study
Abstract Proof‐of‐concept in clinical trials has traditionally focused on the identification of a maximum tolerated dose with the assumption that the higher doses provide better efficacy. However, adverse events associated with a maximum tolerated dose may have a negative effect on efficacy. We present an efficient adaptive dose‐finding strategy that …